| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-0954-03 |
| P698 | PubMed publication ID | 14977821 |
| P50 | author | Carsten Müller-Tidow | Q23564829 |
| P2093 | author name string | Eric Schulze-Bahr | |
| Hubert Serve | |||
| Wolfgang E Berdel | |||
| Paul M Schneider | |||
| Ralf Metzger | |||
| Thomas Büchner | |||
| Kerstin Becker | |||
| Christian Brandts | |||
| Hartmut Halfter | |||
| Nicola Tidow | |||
| Björn Steffen | |||
| Joachim Schwäble | |||
| Ulf Vogt | |||
| Burkhardt Brandt | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1241-1249 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets | |
| P478 | volume | 10 |
| Q28829149 | 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression |
| Q27334633 | A PTK7/Ror2 Co-Receptor Complex Affects Xenopus Neural Crest Migration |
| Q43830000 | A phase I, dose-finding study of sunitinib combined with cisplatin and 5-fluorouracil in patients with advanced gastric cancer |
| Q34162940 | ALK-activating homologous mutations in LTK induce cellular transformation |
| Q53089081 | Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation. |
| Q36155891 | Aptamers for Targeted Drug Delivery |
| Q33598723 | Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach |
| Q46678485 | CD117 expression in glial tumors |
| Q37687371 | Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells |
| Q93145965 | Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF |
| Q39998991 | Cell-specific aptamer probes for membrane protein elucidation in cancer cells |
| Q38302534 | Cisplatin resistance in germ cell tumours: models and mechanisms |
| Q37565024 | Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells |
| Q42078720 | Comparative expression profile of orphan receptor tyrosine kinase ROR1 in Iranian patients with lymphoid and myeloid leukemias. |
| Q41902817 | Conditions of tumor-associated antigens as a proper target for therapeutic antibodies against solid cancers |
| Q34480771 | Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome |
| Q39016511 | Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells. |
| Q37824603 | EPH-EPHRIN in human gastrointestinal cancers |
| Q39618101 | Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process |
| Q34761951 | Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. |
| Q33850638 | Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. |
| Q37500185 | Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth |
| Q34578326 | HOX deregulation in acute myeloid leukemia |
| Q35108886 | High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma |
| Q40147314 | Hypoxia increases the motility of lung adenocarcinoma cell line A549 via activation of the epidermal growth factor receptor pathway |
| Q46396196 | In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature |
| Q50932947 | Increased coexpression of c-KIT and FLT3 receptors on myeloblasts: independent predictor of poor outcome in pediatric acute myeloid leukemia. |
| Q36451958 | Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7) |
| Q47140507 | Luminescence switch-on detection of protein tyrosine kinase-7 using a G-quadruplex-selective probe |
| Q33925730 | Mapping receptor density on live cells by using fluorescence correlation spectroscopy. |
| Q39355305 | Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis |
| Q39153742 | Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. |
| Q36422314 | Ortho-Stabilized (18) F-Azido Click Agents and their Application in PET Imaging with Single-Stranded DNA Aptamers |
| Q91839621 | PTK-7 Expression in Gastric Cancer: A Prognostic Determinant |
| Q57280332 | PTK7 as a novel marker for favorable gastric cancer patient survival |
| Q42243770 | PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma. |
| Q37255487 | PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance |
| Q34732792 | PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis |
| Q92271121 | PTK7 proteolytic fragment proteins function during early Xenopus development |
| Q38441808 | PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling |
| Q33407676 | Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer |
| Q86445750 | Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer |
| Q34072263 | Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer |
| Q30586597 | Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis |
| Q42283856 | Rare cell proteomic reactor applied to stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics study of human embryonic stem cell differentiation. |
| Q30315828 | Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease |
| Q38402026 | Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy |
| Q24317497 | Regulation of arsenic trioxide-induced cellular responses by Mnk1 and Mnk2 |
| Q90284727 | Role of CD135/CD117 on Prognosis and Overall Survival of Acute Myeloid Leukemia |
| Q28242840 | Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy |
| Q39016263 | Ryk is essential for Wnt-5a-dependent invasiveness in human glioma. |
| Q33754728 | Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway |
| Q36861610 | Systemic therapy for gastric cancer and adenocarcinoma of the gastroesophageal junction: present status and future directions |
| Q24299587 | The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis. |
| Q36126992 | The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells |
| Q21710722 | The many roles of PTK7: A versatile regulator of cell–cell communication |
| Q28290732 | The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARalpha and regulates differentiation of hematopoietic cells |
| Q37905875 | Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update |
| Q90722069 | Tyrosine Kinases in Helicobacter pylori Infections and Gastric Cancer |
| Q34983846 | Tyrosine kinase inhibitors: Multi-targeted or single-targeted? |
| Q45977430 | [Receptor tyrosine kinases in Hodgkin lymphoma as possible therapeutic targets]. |
| Q50421596 | miR‑205‑5p/PTK7 axis is involved in the proliferation, migration and invasion of colorectal cancer cells |
Search more.